Searched for
GLAXO GROUP
Bombay HC tells Shreya Life to rename antibiotic drugThe Bombay High Court has ordered the removal of Shreya Life Sciences’ antibiotic trademark Lefoxin Biox from the register, ruling that it ...- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...
- GSK, Generali Deals ClearedThe Competition Commission of India (CCI) on Monday approved the proposed acquisition of consumer healthcare company GlaxoSmithKline Asia P...
- CCI approves Corona Remedies-GlaxoSmithKline dealDilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona Remedies along with trademark and goodwill.
- Govt clears GlaxoSmithKline's Rs 6,400 crore FDI proposalThe Cabinet Committee on Economic Affairs has approved the proposal of GlaxoSmithKline Pte Limited, Singapore for acquisition of 24.33 per ...
- GSK gets FIPB nod to buy 24.33% more in indian armThe Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33%stake, or 2.06 crore, equity shares in GlaxoSmithKline Pharmace...
- FIPB clears GlaxoSmithKline's Rs 6,400 cr FDI proposalFIPB today cleared Rs 6,400 crore FDI proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm.
- GlaxoSmithKline seeks FIPB nod to hike stake in Indian armGlaxoSmithKline has approached the FIPB to hike stake in its domestic arm by buying 24.33 per cent for an estimated Rs 6,400 crore.
- GlaxoSmithKline Plc's open offer for GSKCH to start on January 17The UK-based GlaxoSmithKline Plc's open offer to acquire 31.8 per cent stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare w...
- UK-based healthcare major GlaxoSmithKline to invest Rs 5,220 cr in India subsidiaryGlaxoSmithKline today announced plans to infuse about Rs 5,220 crore in its Indian subsidiary GSKCH by increasing stake to 75% from 43.2% a...
- Oberoi Group in talks to buy 50% in south Mumbai project held by ICICI VentureThe Oberoi Realty Group is in talks to buy the 50% stake held by ICICI Venture in a residential project in south Mumbai.
- Glaxo to pull out its diabetes drug from European marketAvandia, manufactured by GlaxoSmithKline, once the world’s best-selling diabetes drug, will be withdrawn from the market in Europe and sale...
- Is Complan making tall claims? SC to decide on Horlicks pleaThe Supreme Court today admitted a petition from Glaxo Smithkline over a 2004 TV advertisement by Heinz that claimed the nutrition drink Ho...
- GlaxoSmithKline Q4 profit up 66 pcGlaxoSmithKline PLC, the world's second largest drug maker by revenue, reported Thursday that its fourth-quarter profit soared by 66 percen...
- GSK appoints James Murdoch to boardBritish drugs giant GlaxoSmithKline said on Monday that it has appointed James Murdoch, News Corp Europe and Asia's chairman and chief exec...
- Glaxo's Viehbacher to leave after missing CEO jobChris Viehbacher, who lost out to Andrew Witty in the race to lead GlaxoSmithKline Plc is to leave the world's second largest drugmaker on ...
- Ranbaxy to ink R&D deal with foreign coClose on the heels of striking a strategic alliance with domestic pharma company Orchid, Ranbaxy is close to signing a significant research...
- Safety scare over Glaxo drug fuels talks of tougher laws in USLaw makers are seizing on last month’s study linking GlaxoSmithKline’s diabetes drug Avandia and heart risks to press for new US drug-safet...
- Glaxo's bird flu drug to hit market next yearA bird flu vaccine for humans that uses only a very low dose of active ingredient has proved effective in clinical tests and could be mass ...
- Glaxo, Merck to bring in cancer vaccines in IndiaGlaxoSmithKline and Merck will work with groups including the Bill and Melinda Gates Foundation to bring cervical cancer vaccines to the de...
Load More
